Companion Animal Drugs Market
According to Intent Market Research, the Companion Animal Drugs Market is expected to grow from USD 15.1 billion in 2023 at a CAGR of 5.9% to touch USD 22.6 billion by 2030. The Companion Animal Drugs Market is dominated by key players such as Boehringer Ingelheim, Ceva Santé Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health, Heska Corporation, IDEXX Laboratories, Inc. and Merck.